<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01285011</url>
  </required_header>
  <id_info>
    <org_study_id>RECON-EMEA-08</org_study_id>
    <nct_id>NCT01285011</nct_id>
  </id_info>
  <brief_title>Short Term Follow-up of Patient Implanted With the Proximal Interphalangeal Implant</brief_title>
  <official_title>Short Term Follow-up of Patient Implanted With the Proximal Interphalangeal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integra LifeSciences Services</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Integra LifeSciences Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hammertoe and ClawToe are ones of the most common foot deformities. The second toe is the&#xD;
      most frequently affected, but the other small toes may also be involved. When nonoperative&#xD;
      treatment fails, surgery often is recommended. One surgical option is the arthrodesis of the&#xD;
      Proximal Interphalangeal (PIP) joint. This arthrodesis is technically demanding, its needs:&#xD;
&#xD;
        -  Internal fixation;&#xD;
&#xD;
        -  Interphalangeal Compression;&#xD;
&#xD;
        -  Anatomic PIP joint plantar flexion angle. The implant Ipp-On has been developed for this&#xD;
           specific arthrodesis. The objective of this study is to evaluate the efficacy and safety&#xD;
           of the Proximal Interphalangeal Implant: Ipp-On at short term follow up.&#xD;
&#xD;
      The safety of the Ipp-On will be described in terms of rate of device related complications.&#xD;
&#xD;
      The efficacy of the Ipp-On will be described in terms of fusion rate at 6 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of device related complications</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fusion rate</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fusion rate</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>American Orthopaedic Foot and Ankle Society Lesser Metatarsophalangeal Scale (AOFAS LMIS) score</measure>
    <time_frame>6 months/12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological Evaluation</measure>
    <time_frame>6 months/12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Assessment</measure>
    <time_frame>6 months/12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective assessment</measure>
    <time_frame>6 months/12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">156</enrollment>
  <condition>Hammer Toe</condition>
  <condition>Claw Toe</condition>
  <condition>Shortening 2nd Toe</condition>
  <condition>Revision of Arthrodesis or Arthroplasty Failure</condition>
  <arm_group>
    <arm_group_label>Ipp-On</arm_group_label>
    <description>Patient implanted with the Ipp-On</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient who needs a proximal interphalangeal joint arthrodesis for whose surgeon has&#xD;
        recommended that a proximal Interphalangeal Implant Ipp-On be implanted&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any patient who needs a proximal interphalangeal joint arthrodesis for whose surgeon&#xD;
             has recommended that a proximal Interphalangeal Implant Ipp-On be implanted&#xD;
&#xD;
          -  Age &gt;= 18 years&#xD;
&#xD;
          -  Have willingness to give his/her Data Transfer Authorization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication of the implantation of the Ipp-On The implant should not be used in a&#xD;
             patient who has currently, or who has a history of: â€¢ Active local or systemic&#xD;
             infection&#xD;
&#xD;
               -  Severe peripheral vascular disease&#xD;
&#xD;
               -  Severe longitudinal deformity&#xD;
&#xD;
               -  Insufficient quantity or quality of bone to permit stabilization of the&#xD;
                  arthrodesis&#xD;
&#xD;
               -  Conditions that restrict the patient's ability or willingness to follow&#xD;
                  postoperative instructions during the healing process&#xD;
&#xD;
               -  Suspected or documented metal allergy or intolerance.&#xD;
&#xD;
          -  History of prior mental illness or patient demonstrates that their mental capacity may&#xD;
             interfere with their ability to follow the study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sint Lucas Clinic</name>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICP</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale di Bellinzona e Valli</name>
      <address>
        <city>Bellinzona</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>January 26, 2011</study_first_submitted>
  <study_first_submitted_qc>January 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2011</study_first_posted>
  <last_update_submitted>September 10, 2014</last_update_submitted>
  <last_update_submitted_qc>September 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>arthrodesis</keyword>
  <keyword>PIP joint</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hammer Toe Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

